Botulinum Toxin Type A Nabota 100 Units Injection

Botulinum Toxin Type A Nabota 100 Units Injection

₹ 10,000 / Box

MOQ2 Box
Brand NameNabota 200 Mg Injection
FormLiquid
Packaging TypeBox
Packaging SizeBoxes
Supply TypeManufacturer, Exporter, Supplier, Retailer, Distributor, Importer, Trader, Buying House
Preferred Buyer Location All over the world

Company Information

Member Since 1 Year
Nature of Business Manufacturer
GST No. 06AAFCA0130M1Z1

Ask for more detail from the seller

Report incorrect details

Product Details
Company Details

ContainQuality
Brand NameNabota 200 Mg Injection
FormLiquid
Packaging TypeBox
Packaging SizeBoxes
Country of OriginIndia
DosagePrescription
StorageCold dry places

Product Description

clostridium botalium inj

Indications / Uses Botulinum Toxin Type A (Nabota) is indicated for the treatment of blepharospasm associated with dystonia, including benign essential blepharospasm, hemifacial spasm or VIIth nerve disorders in patients 12 years or older.

Botulinum Toxin Type A (Nabota) is indicated for the correction of strabismus in patients 12 years or older.

Botulinum Toxin Type A (Nabota) is indicated for the treatment of spasmodic torticollis (cervical dystonia) in adults.

Botulinum Toxin Type A (Nabota) is indicated for the treatment of dynamic equinus foot deformity due to spasticity in pediatric cerebral palsy patients, two years of age or older.

Botulinum Toxin Type A (Nabota) is indicated for the temporary treatment of glabellar lines associated with corrugator and/or procerus muscle activity in adult patients below 65 years of age.

Botulinum Toxin Type A (Nabota) is indicated in the management of focal spasticity, including the treatment of spasticity associated with stroke in adults.

Botulinum Toxin Type A (Nabota) is indicated for the treatment of focal hyperhidrosis of the axilla.

Botulinum Toxin Type A (Nabota) is indicated for the temporary improvement in the appearance of upper facial rhytides (glabellar lines, crow's feet and forehead lines) in adults.

Botulinum Toxin Type A (Nabota) is indicated for the prophylaxis of headaches in adults with chronic migraine.

Botulinum Toxin Type A (Nabota) is indicated for the treatment of urinary incontinence due to neurogenic detrusor overactivity e.g., spinal cord injury (SCI) or multiple sclerosis (MI) in adults.